Peter Thomas Bigelow

Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

IPS-Integrated Project Services LLC provides technical consulting services. The firm offers integrated services which focuses on the engineering, construction, project controls, commissioning, qualification, and validation of technically complex facilities in hi-tech and heavily regulated industries. The company was founded by Andrew A. Signore and Joseph A. Blanchard in 1989 and is headquartered in Blue Bell, PA.

xCell Strategic Consulting LLC is a consulting private company based in Paoli, PA. The company provides consulting services to various industries, including pharmaceuticals, bioscience, and healthcare. The company's website provides information about its services, partnerships, and success stories. The CEO of the company is Peter Thomas Bigelow.

Part of Firan Technology Group Corp., IMI, Inc. (Massachusetts) is a company that manufacturers specialty RF circuit board. The company is based in Haverhill, MA. The company was founded in 1971. The CEO is Peter Thomas Bigelow. IMI, Inc. (Massachusetts was acquired by Firan Technology Group Corp. on April 28, 2023 for $2 million.

Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom.